Loading...

Planet 13 Holdings Inc.

PLTH.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.40
CA$-0.01(-1.23%)

Planet 13 Holdings Inc. (PLTH.CN) Financial Performance & Income Statement Overview

Explore the financials of Planet 13 Holdings Inc. (PLTH.CN), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth
18.18%
18.18%
Operating Income Growth
41.87%
41.87%
Net Income Growth
35.07%
35.07%
Operating Cash Flow Growth
142.48%
142.48%
Operating Margin
-35.58%
35.58%
Gross Margin
45.56%
45.56%
Net Profit Margin
-41.93%
41.93%
ROE
-41.69%
41.69%
ROIC
-24.07%
24.07%

Planet 13 Holdings Inc. (PLTH.CN) Income Statement & Financial Overview

View the income breakdown for Planet 13 Holdings Inc. PLTH.CN across both annual and quarterly reports.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$30.28M$32.16M$31.08M$22.78M
Cost of Revenue$17.19M$15.46M$17.39M$14.39M
Gross Profit$13.09M$16.70M$13.69M$8.39M
Gross Profit Ratio$0.43$0.52$0.44$0.37
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$15.77M$16.55M$14.84M$12.04M
Operating Expenses$38.08M$20.02M$14.84M$12.04M
Total Costs & Expenses$55.27M$35.48M$32.23M$26.42M
Interest Income$0.00$30263.00$84580.00$24562.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$3.59M$3.58M$3.23M$3.004M
EBITDA-$2.52M$255455.00$2.08M-$647294.00
EBITDA Ratio-$0.08$0.008$0.07-$0.03
Operating Income-$24.98M-$3.32M-$1.15M-$3.65M
Operating Income Ratio-$0.82-$0.10-$0.04-$0.16
Other Income/Expenses (Net)-$149870.00$403914.00-$2.87M$135214.00
Income Before Tax-$25.13M-$2.92M-$4.02M-$3.51M
Income Before Tax Ratio-$0.83-$0.09-$0.13-$0.15
Income Tax Expense$1.30M$4.49M$4.05M$2.33M
Net Income-$26.44M-$7.41M-$8.07M-$5.85M
Net Income Ratio-$0.87-$0.23-$0.26-$0.26
EPS-$0.09-$0.02-$0.03-$0.03
Diluted EPS-$0.09-$0.02-$0.03-$0.03
Weighted Avg Shares Outstanding$325.16M$325.16M$289.18M$228.44M
Weighted Avg Shares Outstanding (Diluted)$325.16M$325.16M$289.18M$228.44M

Over the last four quarters, Planet 13 Holdings Inc. achieved steady financial progress, growing revenue from $22.78M in Q1 2024 to $30.28M in Q4 2024. Gross profit stayed firm with margins at 43% in Q4 2024 versus 37% in Q1 2024. Operating income totaled -$24.98M in Q4 2024, maintaining a -82% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$2.52M. Net income dropped to -$26.44M, with EPS at -$0.09. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;